COMPANY DETAILS

Morgan Stanley lifts S&P 500's annual target on hopes of earnings-driven rallies

May 13 (Reuters) - Morgan Stanley raised its annual target for the benchmark S&P 500 index on Wednesday, saying U.S. stocks had enough room to rally as companies continue to post strong earnings. The ...

Morgan Stanley boosts S&P 500 target. Why Mike Wilson says the market has already priced in the biggest risks

It’s the season for new stock-market price targets, and Morgan Stanley joined the upper echelon of Wall Street targets for the S&P 500 with its new outlook released Wednesday.

Why inflation could peak in the next month, according to Morgan Stanley

Morgan Stanley's top US economist said a "trifecta" of inflationary pressures could cause price increases to peak in May or June.

Morgan Stanley

Latest stories about Morgan Stanley on Business Insider ...

Inflation from Iranian conflict is transitory hence market strength: Morgan Stanley's Sherry Paul

Sherry Paul, Morgan Stanley, joins 'Closing Bell' to discuss Paul's thoughts on the tech sector, the sectors to favor and much more.

Morgan Stanley lifts China equity targets on earnings, yuan strength

Morgan Stanley has lifted its price targets for major Chinese equity indexes, citing stronger earnings, yuan resilience and China’s entrenched role in global supply chains, CNBC reported on Thursday.

Morgan Stanley flags energy shock as key risk, warns current account deficit may widen to 3%

April's numbers came in stronger than most had expected. GST collections hit an all-time high. Manufacturing and services PMIs both moved higher. Bank credit growth stayed firm, and corporate earnings ...

Morgan Stanley Survey Finds Founders Managing More Complex Tradeoffs for Growth, Capital and Liquidity

About Morgan Stanley Morgan Stanley (NYSE: MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management ...

Morgan Stanley Maintains an “Equal Weight” Rating on Genmab A/S (GMAB)

On May 7, Genmab A/S (NASDAQ:GMAB) reported revenue of $896 million for Q1 2026, rising 25% from $715 million a year earlier.

Morgan Stanley resets Arista stock price target for 2026

Arista Networks spent the first quarter of 2026 in an unusual position. Investor conversations had gone quiet. Questions about customer concentration and margins were dominating the narrative. The ...

Morgan Stanley boosts price targets for China indexes, sees upside through 2Q 2027

China's highly competitive supply chain also makes the country best positioned in the high-end power and green tech space, the strategists said.

Sensex at 89,000 by June 2027? Morgan Stanley picks 7 stocks to ride India’s next capex cycle

Morgan Stanley expects a fresh earnings rebound in Indian equities and sees domestic cyclicals, banks and consumption stocks leading the next market rally.